Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

Clinical trial NCT06958796 · RECRUITING

Trial details

NCT number: NCT06958796
Sponsor: Camille N. Kotton, MD
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Cytomegalovirus Organ Transplant Kidney Transplant; Complications Liver Transplant Complications Simultaneous Liver-Kidney Transplantation; Complications

Start date: 2025-11-27
Primary completion: 2027-12-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.